Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Strategic Therapeutic Intervention to Enhance Linkage to Care in People Who Inject Drugs

NCT03981211 is registered in ClinicalTrials.gov with Kirby Institute as lead sponsor.

NCT NCT03981211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03981211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Strategic Therapeutic Intervention to Enhance Linkage to Care in People Who Inject Drugs
Lead sponsor
Kirby Institute
Phase
Not applicable
Overall status
Terminated
Start date
February 12, 2021
Completion date
September 15, 2025
Enrollment
21 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, liver cirrhoses, liver inflammation